Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Concepta addresses supply chain issues after order delay of myLotus fertility product

Orders increased in the last few months of 2017 and the group expects further new distributors to be appointed in the new year
The company's key product is myLotus, a women's fertility home test

UK healthcare firm Concepta PLC (LON:CPT) said it is taking action to improve its supply chain after issues with a manufacturer resulted in a delay to a significant order.

A labelling quality issue with the company's manufacturer in China meant it did not receive sufficient monitors to meet an order for myLotus fertility metres by the ShanDong WeiHai HaiChen Pharmaceutical Co.

READ: Concepta says myLotus fertility product got an “excellent reception” at meeting of potential distributors in China

The £600,000 Chinese order will now be delivered in January, meaning revenues from the deal will be recognised in the first quarter of 2018 instead of by the end of 2017 as announced in November.

However, chief executive Erik Henau said the company has had a team on the ground over recent months to tackle the issues in its supply chain as it ramps up production.

“The China team will have the support of David Darrock as chief operating officer who has experience in the move from assembling products in a laboratory environment to full scale commercial manufacturing,” he said.

“We enforce strict quality control standards on our products and as such we have commenced a full supply chain evaluation with our suppliers and have implemented a number of measures to strengthen processes, for which we are already seeing significant improvements.

READ: Concepta raises £2mln to fund China expansion

“Despite the impact of these issues I am confident that, following the improvements made, we are entering 2018 in a much stronger position."

In the last few months of 2017 orders have increased and the group expects further new distributors to be appointed in the new year.

Following a recent £2mln fundraise, the company also has sufficient cash to meet its working capital requirements through 2018.

View full CPT profile View Profile

Concepta Timeline

Related Articles

scientist looking through microscope
April 11 2018
Kumaraguru Raja sees “multiple catalysts” in the year ahead which could put a rocket under the share price
April 12 2018
Mission is to make stem cell treatments accessible and affordable to as many people as possible
July 30 2018
Life science generally is developing at an incredible speed, says Joe Anderson

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use